Perioperative outcomes after tracheoplasty: A NSQIP analysis 2014–2016

Romaine F. Johnson, Nathan Eaviz, John M. Truelson, Andrew T. Day

Research output: Contribution to journalArticle

Abstract

Objectives: Tracheoplasty or tracheal resection and are essential components of the care of patients with severe tracheal stenosis. We aimed to study the perioperative outcomes of patients after tracheoplasty or resection using a national surgical registry. Methods: We analyzed the 2014 to 2016 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) participant use file for patients who underwent tracheal resection or tracheoplasty (CPT codes 31750, 31760, 31780, and 31781). We analyzed the perioperative outcomes including length of stay (LOS), dehiscence, unplanned reintubations, unplanned surgeries, and 30-day readmission rates. A random 4:1 sample of non-tracheoplasty patients served as the control group. Results: From 2014 to 2016, 126 patients underwent tracheoplasty. The median age was 56 years (IQR = 45–63). There were 93 (74%) females, 88 (70%) white, and 3.2% (4/126) Hispanic. The median LOS was 7 days (IQR = 5–10 days). Of these, 4.8% (6/126) developed wound infections and 3/126 (2.4%) developed wound dehiscence. Five out of 126 required unplanned reintubation (4.0%) and 16/126 (13%) had an unplanned reoperation. The 30-day unplanned readmission rate was 16% (20/126). The wound infection, unplanned intubations, and readmission rates were significantly higher (P <.005) than the control group. Conclusions: The 30-day perioperative outcomes of adult patients undergoing tracheoplasty showed that adverse events are common, but severe adverse events such as death are rare. Continued research into risk mitigation among these patients is warranted. Level of Evidence: NA. Laryngoscope, 2019.

Original languageEnglish (US)
JournalLaryngoscope
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Wound Infection
Length of Stay
Current Procedural Terminology
Tracheal Stenosis
Laryngoscopes
Control Groups
Quality Improvement
Ambulatory Surgical Procedures
Reoperation
Hispanic Americans
Intubation
Registries
Patient Care
Outcome Assessment (Health Care)
Wounds and Injuries
Research

Keywords

  • ACS NSQIP
  • adults
  • perioperative outcomes
  • Tracheoplasty

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Perioperative outcomes after tracheoplasty : A NSQIP analysis 2014–2016. / Johnson, Romaine F.; Eaviz, Nathan; Truelson, John M.; Day, Andrew T.

In: Laryngoscope, 01.01.2019.

Research output: Contribution to journalArticle

Johnson, Romaine F. ; Eaviz, Nathan ; Truelson, John M. ; Day, Andrew T. / Perioperative outcomes after tracheoplasty : A NSQIP analysis 2014–2016. In: Laryngoscope. 2019.
@article{96057e85303c47bca3929afec307f255,
title = "Perioperative outcomes after tracheoplasty: A NSQIP analysis 2014–2016",
abstract = "Objectives: Tracheoplasty or tracheal resection and are essential components of the care of patients with severe tracheal stenosis. We aimed to study the perioperative outcomes of patients after tracheoplasty or resection using a national surgical registry. Methods: We analyzed the 2014 to 2016 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) participant use file for patients who underwent tracheal resection or tracheoplasty (CPT codes 31750, 31760, 31780, and 31781). We analyzed the perioperative outcomes including length of stay (LOS), dehiscence, unplanned reintubations, unplanned surgeries, and 30-day readmission rates. A random 4:1 sample of non-tracheoplasty patients served as the control group. Results: From 2014 to 2016, 126 patients underwent tracheoplasty. The median age was 56 years (IQR = 45–63). There were 93 (74{\%}) females, 88 (70{\%}) white, and 3.2{\%} (4/126) Hispanic. The median LOS was 7 days (IQR = 5–10 days). Of these, 4.8{\%} (6/126) developed wound infections and 3/126 (2.4{\%}) developed wound dehiscence. Five out of 126 required unplanned reintubation (4.0{\%}) and 16/126 (13{\%}) had an unplanned reoperation. The 30-day unplanned readmission rate was 16{\%} (20/126). The wound infection, unplanned intubations, and readmission rates were significantly higher (P <.005) than the control group. Conclusions: The 30-day perioperative outcomes of adult patients undergoing tracheoplasty showed that adverse events are common, but severe adverse events such as death are rare. Continued research into risk mitigation among these patients is warranted. Level of Evidence: NA. Laryngoscope, 2019.",
keywords = "ACS NSQIP, adults, perioperative outcomes, Tracheoplasty",
author = "Johnson, {Romaine F.} and Nathan Eaviz and Truelson, {John M.} and Day, {Andrew T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/lary.28280",
language = "English (US)",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Perioperative outcomes after tracheoplasty

T2 - A NSQIP analysis 2014–2016

AU - Johnson, Romaine F.

AU - Eaviz, Nathan

AU - Truelson, John M.

AU - Day, Andrew T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: Tracheoplasty or tracheal resection and are essential components of the care of patients with severe tracheal stenosis. We aimed to study the perioperative outcomes of patients after tracheoplasty or resection using a national surgical registry. Methods: We analyzed the 2014 to 2016 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) participant use file for patients who underwent tracheal resection or tracheoplasty (CPT codes 31750, 31760, 31780, and 31781). We analyzed the perioperative outcomes including length of stay (LOS), dehiscence, unplanned reintubations, unplanned surgeries, and 30-day readmission rates. A random 4:1 sample of non-tracheoplasty patients served as the control group. Results: From 2014 to 2016, 126 patients underwent tracheoplasty. The median age was 56 years (IQR = 45–63). There were 93 (74%) females, 88 (70%) white, and 3.2% (4/126) Hispanic. The median LOS was 7 days (IQR = 5–10 days). Of these, 4.8% (6/126) developed wound infections and 3/126 (2.4%) developed wound dehiscence. Five out of 126 required unplanned reintubation (4.0%) and 16/126 (13%) had an unplanned reoperation. The 30-day unplanned readmission rate was 16% (20/126). The wound infection, unplanned intubations, and readmission rates were significantly higher (P <.005) than the control group. Conclusions: The 30-day perioperative outcomes of adult patients undergoing tracheoplasty showed that adverse events are common, but severe adverse events such as death are rare. Continued research into risk mitigation among these patients is warranted. Level of Evidence: NA. Laryngoscope, 2019.

AB - Objectives: Tracheoplasty or tracheal resection and are essential components of the care of patients with severe tracheal stenosis. We aimed to study the perioperative outcomes of patients after tracheoplasty or resection using a national surgical registry. Methods: We analyzed the 2014 to 2016 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) participant use file for patients who underwent tracheal resection or tracheoplasty (CPT codes 31750, 31760, 31780, and 31781). We analyzed the perioperative outcomes including length of stay (LOS), dehiscence, unplanned reintubations, unplanned surgeries, and 30-day readmission rates. A random 4:1 sample of non-tracheoplasty patients served as the control group. Results: From 2014 to 2016, 126 patients underwent tracheoplasty. The median age was 56 years (IQR = 45–63). There were 93 (74%) females, 88 (70%) white, and 3.2% (4/126) Hispanic. The median LOS was 7 days (IQR = 5–10 days). Of these, 4.8% (6/126) developed wound infections and 3/126 (2.4%) developed wound dehiscence. Five out of 126 required unplanned reintubation (4.0%) and 16/126 (13%) had an unplanned reoperation. The 30-day unplanned readmission rate was 16% (20/126). The wound infection, unplanned intubations, and readmission rates were significantly higher (P <.005) than the control group. Conclusions: The 30-day perioperative outcomes of adult patients undergoing tracheoplasty showed that adverse events are common, but severe adverse events such as death are rare. Continued research into risk mitigation among these patients is warranted. Level of Evidence: NA. Laryngoscope, 2019.

KW - ACS NSQIP

KW - adults

KW - perioperative outcomes

KW - Tracheoplasty

UR - http://www.scopus.com/inward/record.url?scp=85073929532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073929532&partnerID=8YFLogxK

U2 - 10.1002/lary.28280

DO - 10.1002/lary.28280

M3 - Article

C2 - 31498450

AN - SCOPUS:85073929532

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

ER -